Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0018801 (
heart failure
)
72,216
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Myocardial involvement in
lupus
erythematosis takes the form of an interstitial myocarditis with cellular infiltration and fibrinoid necrosis. The most lesions are perivascular, and involve the arterioles. The myocardial fibres are involved secondarily to the vascular lesions, or by grossly, damaging sclerosis. The clinical features are variable:--no clinical features, but haemodynamic evidence of abnormal ventricular function, and perhaps sudden death;--arrhythmias and disorders of atrio-ventricular conduction;--
cardiac failure
, which may be due to a genuine cardiomyopathy (a part may be played by hypertension, pulmonary hypertension, renal failure, constrictive pericarditis or haemodynamically major valve disorders);--abnormalities of the coronary trunk in a certain number of cases. If anti-nuclear antibodies are present in a cardiomyopathy, the presence of DLE or of a drug-induced
lupus
syndrome must be suspected. There remain some awkward cases which defy classification, and which systematic use of echocardiography and pericardial and myocardial biopsy may be able to define more accurately.
...
PMID:[The myocardiopathies of systemic lupus erythematosus]. 9 56
17 patients with severe chronic
heart failure
(class III and IV) were prescribed hydralazine, an arterial vasodilatator, orally at doses of 150 mg to 400 mg/day. Considerable clinical improvement was observed in most patients. After 24 to 48 hours the cardiac index rose 79 p. 100, the systolic index by 67 p. 100 and left ventricular work by 73 p. 100, whilst systemic and pulmonary resistances fell by 51 p. 100 and 34 p. 100 respectively. There was no significant change in systemic blood pressure or in heart rate. These results were confirmed at 4 months. Mean pulmonary capillary pressure varied little at the start of treatment but decreased by 52 p. 100 at medium term (4 and 12 months) in this series. No cases of systemic
lupus
erythematosis were observed. The main, but not the only, indication of therapy with dihydralazine is low output
heart failure
with little elevation in the pulmonary capillary pressure, especially in primary cardiomyopathy and valvular regurgitation. At present, treatment should be based on the results of cardiac catheterisation and the dosage adjusted according to the rate of hepatic acetylation.
...
PMID:[Treatment of severe chronic cardiac insufficiency with dihydralazine. Short-and median-term results]. 11 37
Four babies with complete heart block associated with maternal
systemic lupus erythematosus
(
SLE
) are described, together with a 5th baby whose mother had serological abnormalities only. One baby had a rapidly fatal outcome, one has required digoxin for
heart failure
, and the remaining 3 are asymptomatic but remain in complete heart block. Additional manifestations were present in 2 of them. The spectrum of neonatal abnormalities that may occur in association with maternal
SLE
and related connective tissue disorders is discussed, together with the possible causes and the prognosis. We conclude that congenital heart block is more common than had previously been appreciated.
...
PMID:Congenital complete heart block in the newborn associated with maternal systemic lupus erythematosus and other connective tissue disorders. 42 May 26
A patient with a 3-year history of serologically confirmed articular
systemic lupus erythematosus
(
SLE
), who developed uncontrolled
heart failure
due to aortic incompetence and who was successfully treated by aortic valve replacement, is described.
...
PMID:Severe aortic incompetence caused by systemic lupus erythematosus. A case report. 69 14
A relatively high incidence of
heart failure
is noted among patients with
systemic lupus erythematosus
(
SLE
) without clearly defined clinical causes. To evaluate left ventricular performance in patients with
SLE
without evidence of cardiovascular disease, noninvasive measurement of the systolic time intervals was carried out. Simultaneous recording of the electrocardiogram, phonocardiogram and carotid arterial pulsation were obtained in 25 patients with
systemic lupus erythematosus
and compared with 22 normal subjects. The patients with
SLE
had a shorter left ventricular ejection time (P less than 0.05), a longer pre-ejection period (P less than 0.02) and an increased ratio of pre-ejection period/left ventricular ejection time (P less than 0.005). These abnormalities on ventricular function were independent of age, duration of the disease, hypertension, renal involvement, anemia, immunologic activity and corticosteroid treatment. Several etiologic possibilities are discussed and the clinical usefulness of this method to detect and follow-up the cardiac dysfunction in
systemic lupus erythematosus
is emphasized.
...
PMID:Myocardial involvement in systemic lupus erythematosus. A noninvasive study of left ventricular function. 69 53
Seven patients with myasthenia gravis developed clinical signs of arthropathy. In two patients, the symptoms were due to a deforming rheumatoid arthritis and the myasthenic symptoms appeared as a transitory phase during the course of the disease. Muscle antibodies of IgG class were demonstrated with sera from both patients. Autoreactivity between muscle antibodies and rheumatoid factor was detected in one patient. Both patients died from sudden
cardiac failure
. Necropsy was performed in one and revealed a spotty myocardial necrosis. One patient had juvenile rheumatoid arthritis. Two patients had mild articular symptoms with indices of multivisceral disease and serological findings indicating a systemic
lupus
erythematous. One patient had classical ankylosing spondylitis, and one, unspecified arthropathy.
...
PMID:Arthritis in myasthenia gravis. 110 89
This review is focused on the roles of laboratory test in acute renal failure (ARF). The roles of the laboratory test changes along with the alterations in clinical features and with the advances of treatment. Recent acute renal failure is characterized by the following three features: most of the ARF develops in hospitals, the frequency of nonoliguric ARF is increasing, and the association of other organ failure such as
heart failure
, liver failure or respiratory failure, increases the mortality rate. Hemodialysis is instituted in the early phase of ARF to enable the supply of enough nutriments and drugs. These features of recent ARF increases the importance of the frequent analysis of plasma creatinine in patients, who are at risk for ARF, to diagnose ARF at the onset. After the development of ARF, laboratory tests for the evaluation of other organ function is repeated. The development of new drugs increases the incidence of interstitial nephritis, and the advances in the therapeutic approach on systemic diseases (such as
SLE
or PN), which frequently develop ARF, alter the prognosis of these diseases. Since the early diagnosis of these diseases is important, it is necessary to develop noninvasive and reliable tests for the diagnosis of these diseases.
...
PMID:[Laboratory tests in acute renal failure]. 130 7
Chagas' disease, caused by the intracellular protozoan parasite Trypanosoma cruzi, is a major cause of
heart failure
in endemic areas. Antigenic mimicry by T. cruzi antigens sharing epitopes with host macromolecules has been implicated in the pathogenesis which is thought to have a significant autoimmune component. We report herein on the cloning and characterization of a full-length cDNA from a T. cruzi expression library encoding a protein, TcP0, that is homologous to the human 38-kD ribosomal phosphoprotein HuP0. The T. cruzi P0 protein shows a clustering of residues that are evolutionarily conserved in higher eukaryotes. This includes an alanine- and glycine-rich region adjacent to a highly charged COOH terminus. This "hallmark" domain is the basis of the crossreactivity of the highly immunogenic eukaryotic P protein family. We found that T. cruzi-infected individuals have antibodies reacting with host (self) P proteins, as well as with recombinant TcP0. Deletion of the six carboxy-terminal amino acids abolished the reactivity of the T. cruzi infection sera with TcP0. This is similar to the specificity of anti-P autoantibodies described for a subset of patients with
systemic lupus erythematosus
(
SLE
) (Elkon, K., E. Bonfa, R. Llovet, W. Danho, H. Weissbach, and N. Brot. 1988. Proc. Natl. Acad. Sci. USA. 85:5186). These results suggest that T. cruzi P proteins may contribute to the development of autoreactive antibodies in Chagas' disease, and that the underlying mechanisms of anti-P autoantibody may be similar in Chagas' and
SLE
patients. This study represents the first definitive report of the cloning of a full-length T. cruzi antigen that mimics a characterized host homologue in structure, function, and shared antigenicity.
...
PMID:Cloning and expression of Trypanosoma cruzi ribosomal protein P0 and epitope analysis of anti-P0 autoantibodies in Chagas' disease patients. 137 23
We report a 46-year-old patient with longstanding
systemic lupus erythematosus
(
SLE
) who developed rapidly progressive
heart failure
and died. At postmortem, there was a unique picture of hemorrhage and mild inflammation present in the myocardium causing the
heart failure
. As far as we are aware, this picture has not been described before in
SLE
and is similar to that seen in the cardiac allograft hyperacute rejection.
...
PMID:Acute hemorrhagic myocarditis in systemic lupus erythematosus. 140 84
A 46 year old woman presented with fever and normochromic anaemia followed rapidly by severe
myocardial failure
, unresponsive to maximum inotropic support and broad spectrum antibiotics. There were no classical clinical stigmata of
systemic lupus erythematosus
(
SLE
) but a possible immunological cause was looked for, and on the basis of her immuno-serology a diagnosis of
SLE
-like disease was made. She responded rapidly to high dose steroids. The importance of considering the possibility of
SLE
or '
lupus
overlap' in an acutely ill 'undiagnosed' patient is emphasized. The relevance of instigating appropriate immuno-serological tests in the course of such an illness is discussed.
...
PMID:Sub-clinical systemic lupus erythematosus presenting with acute myocarditis. 143 35
1
2
3
4
5
6
7
8
9
10
Next >>